8158 — China Regenerative Medicine International Share News
0.000.00%
Last trade - 00:00- HK$66.94m
- HK$103.36m
- HK$72.06m
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital
Brief: China Regenerative Medicine International Proposes To Implement Share Consolidation
Brief: China Regenerative Medicine International Says Made Application For Resumption Of Trading
Brief: China Regenerative Medicine International's Shares To Be Suspended From April 3
Brief: China Regenerative Medicine International Says Wong Po Tin Appointed As CFO
Brief: China Regenerative Medicine International Posts Profit For Year Attributable Hk$13.3 Million
Brief: China Regenerative Medicine International Says Co Unlikely To Publish 2021 Audited Annual Results On Or Before 31 Mar
Brief: China Regenerative Medicine International Says Lee Pak Chung Will Cease To Be Chief Financial Officer
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$404.2 MLN
Brief: China Regenerative Medicine International Says Entered MoU With Jinxin Holdings
Brief: China Regenerative Medicine International Says Qiu Bin Resigns As Execute Director
Brief: China Regenerative Medicine Says Change Of Domicile, Capital Reorganisation To Not Proceed
Brief: China Regenerative Medicine International QTRLY Revenue From Cont Ops HK$64.1 Mln
Brief: China Regenerative Medicine International To Issue Convertible Bonds
Brief: China Regenerative Medicine International To Issue Aggregate Of 230 Mln Subscription Shares
Brief: China Regenerative Medicine International Announces Placing Of Shares